Florida / New York / No Carolina
Ph: 561.316.3330

Tianlong Promotes Environmental Sustainability and Hygiene Monitoring with its Biolum Portable ATP Hygiene Monitoring System Series

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...


  • With the ability to generate results in just 10 seconds and a remarkable detection sensitivity of up to 10-16 mol of ATP, the Biolum Pro sets a new standard in efficiency and accuracy.

In honor of World Environment Day on 5 June, Tianlong, an innovative R&D company specializing in molecular diagnostic products, demonstrates its dedication to environmental sustainability and cleanliness through the introduction of the Biolum Portable ATP Hygiene Monitoring System Series. Utilizing advanced technology, Tianlong is transforming the way hygiene standards are monitored and maintained in various environments.

Tianlong’s Biolum Portable ATP Hygiene Monitoring System, a powerful tool for implementing and overseeing hygiene monitoring programs, has achieved outstanding performance, earning certification from the prestigious AOAC Research Institute’s Performance Tested Methods (PTM) Program. The PTM Program developed more than 30 years ago provides independent third-party review and certification for proprietary test method performance, and has played a crucial role with emerging health concerns by providing a widely accepted certification in a fast-to-market context.

This certification offers users a reliable assessment of the product’s performance, ensuring it meets the highest standards for its intended purpose, and protecting users through trusted, reliable testing methods and products. This validation underscores Tianlong’s commitment to excellence and quality, setting a benchmark for reliability and effectiveness in hygiene monitoring systems.

Through relentless dedication to innovation, Tianlong has introduced the Biolum Pro, the next-generation hygiene monitoring system. With the ability to generate results in just 10 seconds and a remarkable detection sensitivity of up to 10-16 mol of ATP, the Biolum Pro sets a new standard in efficiency and accuracy. The intuitive smartphone design with 5-inch touch shatter-proof screen ensures user-friendly operation. Cloud-based data management enables users to monitor, track, and trend testing results across multiple facilities, making risk management easier than ever. The Biolum Pro innovates to make everything easier and maximize its value to the business.

In Russia, Tianlong’s Biolum series has garnered extensive utilization in the food service sectors. Customers spanning the dairy, meat, fish, and confectionery industries have embraced the Biolum series for conducting rigorous testing to monitor cleanliness standards during production and transportation processes, a critical aspect of ensuring product quality and safety. The exceptional performance of Tianlong’s Biolum series, characterized by its user-friendly interface, flexibility in application, and remarkable accuracy has been instrumental in helping the industry maintain high standards of cleanliness and hygiene. The consistent delivery of reliable results has not only bolstered customer’s confidence in the product but has also enhanced operational efficiency and quality control measures in the industry.

The Biolum series sets a new standard for cleanliness assessment, ensuring not only efficiency but also a sustainable approach to environmental care. By integrating technological innovation with a commitment to cleanliness and sustainability, Tianlong is paving the way for a healthier and greener future for all.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

SOPHiA GENETICS Launches New Residual Acute Myeloid (RAM) Application

Philippe Menu, M.D., PhD., Chief Medical Officer and Chief Product Officer, SOPHiA GENETICS. "We are proud to contribute to the fight against AML through our SOPHiA DDM™ RAM Solution. In particular we feel that the capability to seamlessly track longitudinally the evolution of individual mutations over time through a dedicated add-on module of our SOPHiA DDM™ Platform has the potential to be a game-changer for clinical researchers."

Aurion Biotech Receives Breakthrough Therapy Designation and Regenerative Medicine Advanced Therapy Designation for Its Drug Candidate AURN001

Sterling Chung, Vice President of Regulatory Affairs and Quality at Aurion Biotech. “These designations underscore the importance of developing a potential solution for millions of patients around the world who suffer from corneal endothelial diseases. We look forward to working closely with the FDA to expedite the development of our cell therapy.”

Golidocitinib Approved in China as First-in-class JAK1 Only Inhibitor for Treatment of Relapsed or Refractory Peripheral T-Cell Lymphoma

Golidocitinib is a first-in-class Janus kinase 1 (JAK1) only inhibitor approved for the treatment of r/r PTCL based on results from the multinational pivotal JACKPOT8B study.

By using this website you agree to accept Medical Device News Magazine Privacy Policy